 |
PDBsum entry 2jm4
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Signaling protein
|
PDB id
|
|
|
|
2jm4
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
J Biol Chem
282:4172-4184
(2007)
|
|
PubMed id:
|
|
|
|
|
| |
|
The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation.
|
|
E.J.Hopkins,
S.Layfield,
T.Ferraro,
R.A.Bathgate,
P.R.Gooley.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The receptors for the peptide hormones relaxin and insulin-like peptide 3
(INSL3) are the leucine-rich repeat-containing G-protein-coupled receptors LGR7
and LGR8 recently renamed as the relaxin family peptide (RXFP) receptors, RXFP1
and RXFP2, respectively. These receptors differ from other LGRs by the addition
of an N-terminal low density lipoprotein receptor class A (LDLa) module and are
the only human G-protein-coupled receptors to contain such a domain. Recently it
was shown that the LDLa module of the RXFP1 and RXFP2 receptors is essential for
ligand-stimulated cAMP signaling. The mechanism by which the LDLa module
modulates receptor signaling is unknown; however, it represents a unique
paradigm in understanding G-protein-coupled receptor signaling. Here we present
the structure of the RXFP1 receptor LDLa module determined by solution NMR
spectroscopy. The structure is similar to other LDLa modules but shows small
differences in side chain orientations and inter-residue packing. Interchange of
the module with the second ligand binding domain of the LDL receptor, LB2,
results in a receptor that binds relaxin with full affinity but is unable to
signal. Furthermore, we demonstrate via structural studies on mutated LDLa
modules and functional studies on mutated full-length receptors that a
hydrophobic surface within the N-terminal region of the module is essential for
activation of RXFP1 receptor signal in response to relaxin stimulation. This
study has highlighted the necessity to understand the structural effects of
single amino acid mutations on the LDLa module to fully interpret the effects of
these mutations on receptor activity.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 1.
FIGURE 1. A, stereo view of the ensemble of the 24 lowest
energy structures of the RXFP1 receptor LDLa module. B, ribbon
representation of the RXFP1 receptor LDLa module. -Strands
are colored aqua and the 3[10] helix red/yellow. C, overlay of
the RXFP1 receptor LDLa module on the x-ray crystal structure of
LB5. The r.m.s.d. of the overlay is 1.9 Å. Although not
represented by MOLMOL, NOE data suggest that there is a second
3[10] helix in the C-terminal region of RXFP1 LDLa as seen in
the LB5 structure. D, comparison of side chain orientation of
Phe-10 in relation to LB5. The side chains of RXFP1 LDLa are
blue and those of LB5 are red. Both phenylalanine residues pack
against an unconserved residue; however, the [1] of the RXFP1 Phe-10
is +60, whereas in LB5 and other LDLa modules it is +180. E,
overlay of residues that bind the calcium ion necessary for
structure. Residues of the RXFP1 LDLa module are colored blue
and LB5 red. Numbering is by the RXFP1 sequence.
|
 |
Figure 3.
FIGURE 3. RP-HPLC profiles of GB1-LDLa and variants. The
top elution profile is of the protein oxidized in the presence
of 2.5 mM CaCl[2]. The second profile is the protein oxidized in
the absence of calcium chloride and in the presence of 1 mM
EDTA. The third profile is the unfolded protein in the presence
of 1 mM dithiothreitol (DTT). GB1-LDLa L7A and GB1-LDLa L22
generate elution profiles very similar to the wild type protein
that elutes as a single peak when oxidized in the presence of
calcium or as multiple peaks when oxidized in the presence of
EDTA. Refolding of GB1-LDLa Y9A, GB1-LDLa F10A, and GB1-LDLa
L23A appears to be disrupted by each mutation, as the proteins
oxidized in the presence of calcium elute as several peaks. The
fraction collected that appeared to be folded by NMR is
indicated with shading and an arrow. The other fractions
collected were assessed as unfolded by NMR.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2007,
282,
4172-4184)
copyright 2007.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
M.Bieri,
A.H.Kwan,
M.Mobli,
G.F.King,
J.P.Mackay,
and
P.R.Gooley
(2011).
Macromolecular NMR spectroscopy for the non-spectroscopist: beyond macromolecular solution structure determination.
|
| |
FEBS J,
278,
704-715.
|
 |
|
|
|
|
 |
A.Donizetti,
M.Fiengo,
R.del Gaudio,
R.Di Giaimo,
S.Minucci,
and
F.Aniello
(2010).
Characterization and developmental expression pattern of the relaxin receptor rxfp1 gene in zebrafish.
|
| |
Dev Growth Differ,
52,
799-806.
|
 |
|
|
|
|
 |
G.E.Callander,
and
R.A.Bathgate
(2010).
Relaxin family peptide systems and the central nervous system.
|
| |
Cell Mol Life Sci,
67,
2327-2341.
|
 |
|
|
|
|
 |
X.J.Du,
R.A.Bathgate,
C.S.Samuel,
A.M.Dart,
and
R.J.Summers
(2010).
Cardiovascular effects of relaxin: from basic science to clinical therapy.
|
| |
Nat Rev Cardiol,
7,
48-58.
|
 |
|
|
|
|
 |
A.J.Ramsay,
J.D.Hooper,
A.R.Folgueras,
G.Velasco,
and
C.López-Otín
(2009).
Matriptase-2 (TMPRSS6): a proteolytic regulator of iron homeostasis.
|
| |
Haematologica,
94,
840-849.
|
 |
|
|
|
|
 |
B.J.Hartley,
D.J.Scott,
G.E.Callander,
T.N.Wilkinson,
D.E.Ganella,
C.K.Kong,
S.Layfield,
T.Ferraro,
E.J.Petrie,
and
R.A.Bathgate
(2009).
Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function.
|
| |
Ann N Y Acad Sci,
1160,
67-73.
|
 |
|
|
|
|
 |
G.W.Tregear,
R.A.Bathgate,
M.A.Hossain,
F.Lin,
S.Zhang,
F.Shabanpoor,
D.J.Scott,
S.Ma,
A.L.Gundlach,
C.S.Samuel,
and
J.D.Wade
(2009).
Structure and activity in the relaxin family of peptides.
|
| |
Ann N Y Acad Sci,
1160,
5.
|
 |
|
|
|
|
 |
E.T.van der Westhuizen,
M.L.Halls,
C.S.Samuel,
R.A.Bathgate,
E.N.Unemori,
S.W.Sutton,
and
R.J.Summers
(2008).
Relaxin family peptide receptors--from orphans to therapeutic targets.
|
| |
Drug Discov Today,
13,
640-651.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |